Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Annals of Surgical Oncology|June 11, 2020
Correction to: ASO Author Reflections: Addition of Induction Chemotherapy Prior to Neoadjuvant Chemo(Re)Irradiation in Patients with Locally Recurrent Rectal Cancer to Improve Long-Term OutcomesEva L K Voogt, Jacobus W A Burger, Harm J T RuttenThe British Journal of Surgery|April 13, 2022
Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral unitsStefi Nordkamp, Eva L K Voogt, Desley M G I van Zoggel, et al.International Journal of Radiation Oncology, Biology, Physics|June 19, 2021
Prognostic Implications of MRI-Detected EMVI and Tumor Deposits and Their Response to Neoadjuvant Therapy in cT3 and cT4 Rectal CancerDennis P Schaap, Eva L K Voogt, Jacobus W A Burger, et al.BJS Open|May 13, 2022
MRI tumour regression grade in locally recurrent rectal cancerEva L K Voogt, Stefi Nordkamp, Desley M G I van Zoggel, et al.International Journal of Radiation Oncology, Biology, Physics|February 10, 2021
Intraoperative Electron Beam Radiation Therapy (IOERT) Versus High-Dose-Rate Intraoperative Brachytherapy (HDR-IORT) in Patients With an R1 Resection for Locally Advanced or Locally Recurrent Rectal CancerEva L K Voogt, Jan M van Rees, Jan A W Hagemans, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 3, 2021
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancerDesley M G I van Zoggel, Eva L K Voogt, Ineke G van Lijnschoten, et al.Journal of Contemporary Brachytherapy|October 6, 2022
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancerAn-Sofie E Verrijssen, Wim J F Dries, Jeltsje S Cnossen, et al.Pageof 1